NECLIFE

Pharmaceuticals

NECTAR LIFESCIENCES LTD.

NSE: NECLIFEBSE: 532649ISIN: INE023H01027

₹13.56

-0.80 · -5.57%

As of 11 May 2026

Open

₹14.18

High

₹14.25

Low

₹13.50

Prev Close

₹14.36

52W High

₹28.25

52W Low

₹9.30

Volume

7.00 L

Mkt Cap

₹231 Cr

Fundamentals

Valuation & profitability

Market Cap

₹231 Cr

P/E Ratio

—

EPS (TTM)

₹-1.00

Book Value

—

Dividend Yield

—

ROCE

—

ROE

—

Sales Growth

—

Face Value

—

Key highlights

Auto-generated from live data

NECLIFE is trading above 4 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
At ₹13.56 it sits about 22% of the way up its 52-week range (₹9.30–₹28.25).
Market capitalisation stands at ₹231 Cr.

Price chart

Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC

Shareholding pattern

Shareholding data syncs daily.

Moving averages

Simple moving averages vs current price

4/5 above · Bullish

SMA 10-Day

₹10.76Above

SMA 20-Day

₹11.12Above

SMA 50-Day

₹11.63Above

SMA 100-Day

₹11.64Above

SMA 200-Day

₹13.78Below

Price ranges

Where the price sits in each window

10-Day range₹13.56

₹10.21₹11.33

20-Day range₹13.56

₹10.21₹11.99

50-Day range₹13.56

₹10.21₹13.30

200-Day range₹13.56

₹9.30₹22.40

YTD range₹13.56

₹9.30₹20.90

52-Week range₹13.56

₹9.30₹22.40

Technical signals

Unfilled gaps acting as support / resistance

Unfilled Gap Down On 12 May, 2026 : 13.31 ~ 13.50RESISTANCE

Unfilled Gap Up On 08 Apr, 2026 : 10.21 ~ 10.13SUPPORT

Unfilled Gap Down On 08 Jul, 2025 : 22.05 ~ 22.70RESISTANCE

Annual financials

Revenue, profit & EPS by financial year

Year	Revenue	Net Profit	EPS	NPM
Mar 2023	₹1,525 Cr	₹-22.00 Cr	₹-1.00	-1.44%
Mar 2022	₹1,668 Cr	₹25 Cr	₹1.13	1.5%
Mar 2021	₹1,541 Cr	₹-73.00 Cr	₹-3.27	-4.74%
Mar 2021	₹1,541 Cr	₹-73.00 Cr	₹-3.27	-4.74%
Mar 2020	₹2,363 Cr	₹32 Cr	₹1.42	1.35%
Mar 2020	₹2,363 Cr	₹32 Cr	₹1.42	1.35%
Mar 2019	₹2,779 Cr	₹48 Cr	₹2.12	1.73%
Mar 2019	₹2,779 Cr	₹48 Cr	₹2.12	1.73%
Mar 2018	₹1,874 Cr	₹52 Cr	₹2.33	2.77%
Mar 2017	₹1,635 Cr	₹55 Cr	₹2.47	3.36%
Mar 2016	₹1,674 Cr	₹54 Cr	₹2.42	3.23%
Mar 2015	₹1,638 Cr	₹66 Cr	₹2.93	4.03%

Peer comparison

Other companies in Pharmaceuticals

Company	P/E	Book Value	Sales Growth
SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.	39.1	₹98.33	10.1%
MARKSANS MARKSANS PHARMA LTD.	23.8	₹11.85	5.8%
MOREPENLAB MOREPEN LABORATORIES LTD.	20.81	₹6.43	16.6%
NEULANDLAB NEULAND LABORATORIES LTD.	23.48	₹542.16	9.35%
GUFICBIO Gufic BioSciences Ltd.	24.16	₹10.85	20.41%
DIVISLAB DIVI'S LABORATORIES LTD.	41.01	₹266.77	9.47%
DRREDDY DR.REDDY'S LABORATORIES LTD.	19.73	₹852.69	1.07%
RPGLIFE RPG LIFE SCIENCES LTD.	17.14	₹105.02	5.73%
GLAND Gland Pharma Ltd	53.6	₹242.00	—
ZYDUSLIFE Zydus Lifesciences Ltd	8.23	₹166.00	5%
SMSPHARMA SMS PHARMACEUTICALS LTD.	9.58	₹42.07	-8.73%
CIPLA CIPLA LTD.	15.36	₹209.71	0.7%

Dividend history

Per share, by ex-date

Ex-Date: 11 Sept 2020₹0.05

Ex-Date: 19 Sept 2019₹0.05

Ex-Date: 19 Sept 2018₹0.05

Ex-Date: 20 Sept 2017₹0.05

Ex-Date: 22 Sept 2016₹0.10

Ex-Date: 22 Sept 2015₹0.10

Ex-Date: 21 Aug 2014₹0.10

Ex-Date: 19 Sept 2013₹0.10

Ex-Date: 20 Sept 2012₹0.10

Ex-Date: 21 Sept 2011₹0.10

Ex-Date: 21 Jan 2010₹0.25

Ex-Date: 03 Sept 2009₹0.10

Bulk & block deals

Recent large transactions

Date	Client	Type	Qty	Price
28 Mar 2017	RAMAN GOYAL	SALE	2,15,84,000	₹34.40
28 Mar 2017	SANJEEV AND SONS	PURCHASE	4,28,07,400	₹34.40
28 Mar 2017	SANJIV GOYAL	SALE	2,12,23,400	₹34.40
28 Mar 2017	RAMAN GOYAL	SALE	2,15,84,000	₹34.40
28 Mar 2017	SANJEEV AND SONS	PURCHASE	2,12,23,400	₹34.40
28 Mar 2017	SANJEEV AND SONS	PURCHASE	2,15,84,000	₹34.40
28 Mar 2017	SANJIV GOYAL	SALE	2,12,23,400	₹34.40
22 Mar 2013	CELLCAP INVOFIN INDIA PRIVATE LIMITED	SALE	12,00,000	₹16.00
22 Mar 2013	YASH SHARES AND STOCK PVT LTD	PURCHASE	15,73,732	₹16.00
19 Mar 2013	SAURUBH BORA	SALE	14,43,943	₹19.95
12 Mar 2013	ALOK SUNIL GANDHI	SALE	13,50,000	₹15.05
12 Mar 2013	SAURUBH BORA	PURCHASE	13,38,425	₹15.05

Explore more

Pharmaceuticals sector

Sector peers & index performance

NECLIFE news & filings

Latest corporate announcements

Top Gainers

Biggest NSE gainers today

Top Losers

Biggest NSE losers today

IPO Calendar

Open & upcoming IPOs

Stock Screener

Find more stocks like this

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.